Guidance about Clause 3
Following a number of recent cases the PMCPA has issued guidance on the application of Clause 3 of the Code to various activities.
The guidance covers:
1. The provision of information about unauthorized medicines / indications
2. Promotion at international meetings held in the UK
3. Advance notification of new products or product changes
4. Guidance issued following Health Technology Assessments
5. Pharmaceutical company staff
6. Information to the public.